Simple explanation
The Innovative Genomics Institute was set up by Jennifer Doudna to work on what CRISPR is actually for: treating disease, improving crops, and — unusually — doing it in ways that could reach people who cannot afford two-million-dollar medicines. It runs programmes explicitly aimed at affordability and at individual rare-disease patients.
Go deeper
The Innovative Genomics Institute is a joint University of California, Berkeley and UC San Francisco research centre founded by Jennifer Doudna in 2014. Its work spans therapeutic editing, agricultural genomics, climate applications and public engagement, with an explicit programme on affordable and scalable editing therapies for rare disease.